X-LINKED ADRENOLEUKODYSTROPHY
Clinical trials for X-LINKED ADRENOLEUKODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new X-LINKED ADRENOLEUKODYSTROPHY trials appear
Sign up with your email to follow new studies for X-LINKED ADRENOLEUKODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gene therapy trial offers hope for rare brain disease
Disease control Recruiting nowThis study tests a new gene therapy for X-linked adrenoleukodystrophy (X-ALD), a rare genetic disorder that damages the brain. The therapy uses a modified virus to deliver a working copy of the faulty gene directly into the spinal fluid and bloodstream. The goal is to slow or sto…
Matched conditions: X-LINKED ADRENOLEUKODYSTROPHY
Phase: NA • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Massive leukodystrophy biobank aims to unlock disease secrets
Knowledge-focused Recruiting nowThis study collects medical information and biological samples from up to 12,000 people with leukodystrophies—rare brain disorders affecting white matter. Researchers will use this data to find new genetic causes, develop biomarkers, and better understand how these diseases progr…
Matched conditions: X-LINKED ADRENOLEUKODYSTROPHY
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC